Pinz Capital Management, LP Ampio Pharmaceuticals, Inc. Transaction History

Pinz Capital Management, LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.8 $14,762 - $21,960	-12,200 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $19,032 - $24,156	12,200 New	12,200 $20,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pinz Capital Management, LP with notifications on news.